From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Osteoporosis/Bone Disease>
  4. Archives

Osteoporosis/Bone Disease: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 76-100 of 233 are shown

Guideline for Osteoporosis Screening in Men

Testing is recommended for men at increased risk.

Alendronate and Atrial Fibrillation: Weighing Risks and Benefits

Women who ever used alendronate were at higher risk for atrial fibrillation.

Ustekinumab for Chronic Plaque Psoriasis

This human monoclonal antibody significantly improved PASI scores, but some questions about its use remain.

Pregabalin Is Effective for Treatment of Fibromyalgia

Patients who received pregabalin had significant improvements in pain and sleep.

Are Low Vitamin D Levels Associated with Nonspecific Pain?

The results of two studies argue against any simple relation between diffuse pain and vitamin D deficiency.

Can’t Get a Break: Osteoporotic Fractures and Quality of Life

Women with fragility fractures and inadequate osteoporosis treatment were at increased risk for another fracture within a year, with negative effects on quality of life.

Thiazolidinediones and Risk for Fractures

In an observational study, users of TZDs had higher risk for fractures than those taking other antidiabetes medications.

Alendronate and Risk for Atrial Fibrillation

Because of inconsistent results across several studies, it's still unclear whether oral bisphosphonates increase risk for atrial fibrillation.

Be Still My Heart — Bisphosphonates Not Linked to Arrhythmias

Use of oral bisphosphonates did not increase risk for atrial fibrillation and flutter.

Should We Be Concerned About Jaw Osteonecrosis with Oral Bisphosphonates?

BRONJ probably occurs rarely with oral bisphosphonate therapy, but the true incidence isn’t clear yet.

A New Approach to Osteoporosis and Fracture Risk

A new statistical model predicts 10-year risk for hip and other major fractures.

Oral Bisphosphonates Do Not Increase Risk for Atrial Fibrillation and Flutter

A previous finding of increased risk for atrial fibrillation and flutter after IV bisphosphonate was not observed in orally treated patients.

Effect of Anastrozole on Bone-Mineral Density

Five years of anastrozole therapy did not lead to osteoporosis for any woman with normal BMD at baseline.

A Bad Break in Epilepsy?

Deficits in bone mineral density are found in children with epilepsy, and these deficits worsen as illness duration increases.

Healthcare Expenditures for Spine Problems Have Increased

At the same time, patient functioning has decreased.

Oral Bisphosphonates and Oral Health

Oral BP administration was not associated with increased risk for ONJ.

Does Bisphosphonate Use Cause Aseptic Osteonecrosis?

Although BP use seemed to be associated with aseptic osteonecrosis, cause and effect were not demonstrated.

Spinal Stenosis: Surgical vs. Nonsurgical Therapy

Outcomes with surgery appeared to be superior, but several problematic aspects of this study preclude us from drawing definitive conclusions.

Cardiovascular Risk and Calcium Supplementation in Postmenopausal Women

Calcium supplementation might raise, rather than lower, cardiovascular risk in postmenopausal women.

Healthcare Expenditures for Back and Neck Pain

The costs of treating neck and back and neck pain are high and are increasing, without a corresponding apparent functional benefit.

Bedtime Dose of Modified-Release Prednisone Reduces Morning Arthritis Stiffness

Modified-release prednisone offered greater relief of morning stiffness and no greater risk than immediate-release prednisone.

Falling Through the Cracks: Can Depression Affect BMD?

Women with MDD had lower BMD and higher pro-inflammatory cytokine levels than did women without depression.

Injectable Progestins and Bone Loss: Is It Reversible?

Bone loss observed during DMPA contraceptive use was completely reversed several years after cessation of use.

Vitamin D Compounds Have Uncertain Benefit in Kidney Disease

Results of a meta-analysis indicate that efficacy is unproven.

One Vertebral Fracture Forecasts Another

Women with a current vertebral fracture and osteoporosis had more than 50% absolute risk for another vertebral fracture within 15 years.

Items 76-100 of 233 are shown

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.